• EN

News and events

Media support

To schedule interviews, obtain informed comment, request written contributions or receive the latest news on the agency, please contact our media relations unit:

Kathy Robertson
Head of sector
Media relations and marketing
Tel: (351) 211 21 02 00/32
Fax: (351) 211 21 03 80

Maria José Louro
Media relations assistant
Tel: (351) 211 21 02 00/40
Fax: (351) 211 21 03 80

Click and learn with the EMCDDA’s new-look Best practice portal

(Lisbon, 23.10.2014) Real-life responses to drug problems come under the spotlight today as the EU drugs agency (EMCDDA) launches its revamped Best practice portal. Designed as a practical and reliable source of what works, and what doesn’t, in the areas of drug-related prevention, treatment, harm reduction and social reintegration, the portal is targeted at practitioners and professionals. Read more >>

Drug-related harms and responses in focus at annual EMCDDA expert meetings

(Lisbon, 13.10.2014) Latest evidence in the area of drug overdose, HCV infections and HIV outbreaks among drug users will be among the topics discussed in a series of events unfolding this week at the EU drugs agency (EMCDDA) in Lisbon Read more >>

Second EMDAS graduation ceremony at EMCDDA

(Lisbon, 29.09.2014) The second group of 25 students graduating from the European Masters in Drug and Alcohol Studies (EMDAS), will receive their diplomas at a ceremony at the EMCDDA on 30 September. EMDAS, a project initially funded through the EC-Lifelong Learning Programme, involves three European universities: Århus (Denmark); Universidad Miguel Hernández de Elche (Spain); and Piemonte Orientale ‘A. Avogardo’ (Italy). Read more >>

Four new drugs to be placed under control

(Lisbon, 25.09.2014) Today, EU Ministers adopted a European Commission proposal to control four new psychoactive substances currently raising health concerns in Europe. Read more >>

EMCDDA unites expert networks in integrated approach to monitoring

(Lisbon, 24.09.2014) ‘Continuity and change: high-risk drug use and drug treatment in Europe’, is the focus of events unfolding this week at the EU drugs agency (EMCDDA) in Lisbon. Two parallel EMCDDA expert meetings, dedicated to the agency’s treatment demand indicator (TDI) and the problem drug use indicator (PDU), precede a broader, common event open to specialists from outside the two groups. Read more in fact sheet 10/2014>>

European Parliament President Martin Schulz to visit EU agencies in Lisbon

(Lisbon, 19.09.2014) Newly re-elected President of the European Parliament Martin Schulz will visit the EU drugs agency (EMCDDA) and the European Maritime Safety Agency (EMSA) on 23 September, accompanied by Secretary of State for European Affairs Bruno Maçães and Mayor of Lisbon António Costa. Read more in news release 8/2014>>

ECDC-EMCDDA joint mission on HIV status and hepatitis surveillance in Latvia

(Lisbon, 03.09.2014) At the invitation of the Latvian government, and in the context of high HIV levels in the country, ECDC and the EMCDDA have joined forces to assist national experts in preventing and controlling infectious diseases among different risk groups, including people who inject drugs. Read more >>

Published today: New EMCDDA review on hepatitis C virus infection among people who inject drugs in Europe

(Lisbon, 28.07.2014) People who inject drugs (PWID) are a key population affected by the hepatitis C virus (HCV). Treatment options are improving and may enhance prevention; however access for PWID may be poor. To coincide with World Hepatitis Day, the open-access online journal PLOS ONE publishes the results of an EMCDDA systematic review on data for the scaling up of HCV treatment and prevention for PWID across the European Union. Read more >>

Over 30 years’ experience in the cross-border collection and analysis of information

(Lisbon, 15.07.2014) Wolfgang Götz has been Director of the EMCDDA since May 2005, having been appointed by the agency’s Management Board on 19 April that year. In July 2009, the Board renewed his mandate unanimously for a further five-year term commencing on 1 May 2010. See updated profile here. Read more in fact sheet 8/2014 >>

Eurojust and EMCDDA pledge to boost cooperation

(Lisbon, 15.07.2014) Exchanging strategic and technical information in the areas of drug legislation and supply was among the pledges made today in a Memorandum of Understanding (MoU) signed by the EU drugs agency (EMCDDA) and the EU judicial cooperation unit (Eurojust). At an official ceremony in The Hague, EMCDDA Director Wolfgang Götz and President of Eurojust Michèle Coninsx reaffirmed their agencies’ commitment to strengthening action against illicit drugs and related crime in the EU. Read more in news release 7/2014 >>

Third European drugs summer school opens today in Lisbon

(Lisbon, 30.06.2014) The third European drugs summer school (EDSS) — ‘Illicit drugs in Europe: demand, supply and public policies’ — opens today in Lisbon and will run until 11 July. The initiative, organised by the University Institute of Lisbon (ISCTE) and the EU drugs agency (EMCDDA), is supported by the US National Institute on Drug Abuse (NIDA). Read more in fact sheet 7/2014 >>

EMCDDA releases state-of-the-art review on drugs and driving

(Lisbon, 25.06.2014) An estimated 28 000 lives are lost on Europe’s roads every year and a further 1.34 million people are injured. Many of these accidents and deaths are caused by drivers whose performance is impaired by a psychoactive substance.  In a new report out today, Drug use, impaired driving and traffic accidents, the EU drugs agency (EMCDDA) reviews the latest research in this field. Read more in news release 6/2014 >>

Largest multi-city study on drug wastewater analysis released today

(Lisbon, 27.05.2014) The findings of the largest European project to date in the emerging science of wastewater analysis (WWA) are released today in an article published in Addiction. The project in question — steered by the Europe-wide SCORE network — analysed wastewater in over 40 European cities to explore the drug-taking habits of those who live in them. Read more in news release 5/2014 >>

EU drugs agency places six topics in the spotlight with new online analyses

(Lisbon, 27.05.2014) The EMCDDA releases today alongside its European Drug Report 2014: Trends and developments, six new additions to its Perspectives on drugs (PODs) series. This latest selection of online, interactive analyses provides a state-of-the-art review of key aspects of the European drug situation. Read more in news release 4/2014 >>

European Drug Report out today — Europe’s drugs problem ‘increasingly complex’

(Lisbon, 27.05.2014) Europe’s drugs problem is becoming increasingly complex with new challenges emerging that raise concerns for public health. This is according to the European Drug Report 2014: Trends and developments released today by the EMCDDA. Read more in news release 3/2014 >>

International experts to examine latest findings in the field of new drugs

(Lisbon, 15.05.2014) Third international conference on novel psychoactive substances opens today in Rome. Read more in fact sheet 6/2014 >>

EU drugs agency to launch European Drug Report 2014

(Lisbon, 24.04.2014) The EMCDDA will be presenting its annual overview of the European drug situation on 27 May in a multilingual, multimedia information package focusing on today’s rapidly shifting drug phenomenon. Read more in news release 2/2014 >>

EMCDDA and ECDC facilitate sub-regional exchange of knowledge and best practice in monitoring and preventing drug-related infections

(Lisbon, 07.04.2014) Monitoring and responding to HIV and hepatitis C among people who inject drugs (PWID) is the focus of two new reports from the EU drugs agency (EMCDDA) and the European Centre for Disease Prevention and Control (ECDC). Read more >>

EMCDDA Scientific Committee elects new leaders

(Lisbon, 01.04.2014) The EMCDDA Scientific Committee, meeting in Lisbon this week, elected its new Chair and Vice Chair for the next three years. Prof. Dr Gerhard Bühringer (Germany) was elected to the position of Chair and Dr Anne Line Breteville-Jensen (Norway) to the position of Vice Chair. Read more in fact sheet 5/2014 >>

Regional drug strategies across the world explored in new EMCDDA paper

(Lisbon, 18.03.2014) The EU drugs agency (EMCDDA) has released today its first comparative analysis of regional drug strategies across the world. The paper explores the drug strategies and action plans adopted over the last five years by six intergovernmental organisations, engaging 148 countries in four continents. Read more in fact sheet 4/2014 >>

Dangerous synthetic drugs hit the EU market

(Lisbon, 07.03.2014) Europol and the EMCDDA have issued today early-warning notifications about two synthetic drugs that have recently been linked to serious harms in the EU. Read more >>

New EMCDDA technical assistance project with ENP countries kicks off today

(Lisbon, 05.03.2014) A new, two-year technical cooperation project between the EU drugs agency (EMCDDA) and countries of the European Neighbourhood Policy (ENP) kicks off today in Lisbon. The project takes place within the EMCDDA’s mandate for cooperation with third (non-EU) countries, as set out in its recast founding regulation in 2006. Read more in fact sheet 3/2014 >>

EMCDDA embarks on 2014 work programme

(Lisbon, 13.02.2014) The EMCDDA’s 2014 work programme — adopted by the Management Board on 5 December and published today — takes forward work begun in 2013 to implement the core principles of the EMCDDA’s 2013–15 strategy and work programme. Three core principles drive this three-year strategy and also shape and focus activities in 2014. These include: delivering a relevant, timely and responsive analysis of the drug situation; achieving efficiency and ensuring that maximum value is delivered from activities and investments; and enhancing communication and a customer-focused approach. Read more >>

EU drugs agency steps up cooperation with Israel Anti-Drug Authority

(Lisbon, 04.02.2014) The European Union and Israel will share information on drugs more systematically in future, thanks to a Memorandum of Understanding signed today in Jerusalem between the EMCDDA and the Israel Anti-Drug Authority (IADA). The agreement was signed at the Israeli Ministry of Foreign Affairs by EMCDDA Director Wolfgang Götz and IADA Director-General Yair Geller. Read more in fact sheet 2/2014 >>

EMCDDA hosts kick-off meeting of EC-funded Joint Action on Reducing Alcohol Related Harm

(Lisbon, 31.01.2014) Harmful and hazardous alcohol use is one of the main causes of premature deaths and avoidable diseases in the EU today. Highlighting the importance of this issue, the European Commission is funding the Joint Action on Reducing Alcohol Related Harm (RARHA) project, being launched in Lisbon on 31 January. Read more  >>

Four new drugs go under the microscope in the wake of rising health concerns

(Lisbon, 29.01.2014) Europe has responded to rising concern over the use of four new drugs by formally requesting a scientific investigation into the health and social risks of the substances. The drugs are: 25I-NBOMe, AH-7921, MDPV and methoxetamine. Read more in news release 1/2014 >>

Registration opens for third European drugs summer school

(Lisbon, 15.01.2014) The University Institute of Lisbon (ISCTE–IUL) and the EU drugs agency (EMCDDA) will be joining forces again in July 2014 to hold the third European summer school on ‘Illicit drugs in Europe: supply, demand and public policies’. Registration opens today for the two-week course, which will take place in the Portuguese capital from 30 June to 11 July. The initiative is supported by the US National Institute on Drug Abuse (NIDA). Read more in fact sheet 1/2014 >>

Download this attachment in CSS format
Download this attachment in CSS format
Download this attachment in GIF format
Download this attachment in GIF format

Page last updated: Tuesday, 21 October 2014